Drug-eluting coronary stent
HT Supreme™ Healing-Targeted DES
A sirolimus-eluting coronary stent system designed around synchronised drug release, polymer degradation and vascular healing.
Open official product page https://www.sinomed.com/products/
Back to portfolioExclusive South African distribution
Global interventional technology. Local clinical support.
Aperture Science represents this featured Sinomed interventional cardiology portfolio in South Africa, supporting healthcare professionals and procurement teams with local product access and documentation.
Official manufacturer URL: www.sinomed.com
South AfricaExclusive distributionAperture Science
Company background
Interventional medicine since 2007.
Sinomed is an interventional medical-device company focused on coronary, neurovascular and structural-heart technologies. The company reports that it was founded in 2007 and is publicly traded on the Shanghai STAR Market under stock code 688108.SH.
Integrated capabilityDevice development and production supported by dedicated research, development and manufacturing facilities.
Clinical programmeThe represented HT Supreme portfolio is supported by PIONEER III long-term evidence and the peer-reviewed 2026 PIONEER IV interim analysis.
South African accessLocal product, clinical-documentation and procurement support through Aperture Science.
Represented portfolio
Coronary intervention
Select a manufacturer link below to leave the Aperture Science website. The verified destination is also printed beneath each button for use where an embedded browser blocks external navigation.
Semi-compliant PTCA balloon
SC Honkytonk®
A semi-compliant coronary balloon catheter developed for lesion preparation, deliverability and controlled dilatation.
Open official product page https://www.sinomed.com/scb-e/
Non-compliant PTCA balloon
NC Rockstar®
A non-compliant coronary balloon catheter for high-pressure post-dilatation and stent optimisation.
Open official product page https://www.sinomed.com/ncp/South African enquiries